Sign inJoin
Company / Finance

McKesson Corporation

MCK · NYSE

McKesson reported FY2026 revenue of $403.4 billion and FY2026 operating income of $6.2 billion. The thesis depends on pharma distribution scale, specialty growth, working capital, margins and cash conversion.

FollowAdd to WatchlistAsk Question
NYSEMCKCoverage BootstrapMcKesson Corporation
Latest ReportMay 20, 2026MCK: McKesson scale needs distribution margins to keep turning into cashView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.

Sign in as admin